NEXGEN-PD

Home of the NEXGEN-PD project, an exciting new Horizon Europe RIA initiative developing the new WISIT vaccine platform, the world's first GNCV vaccine, for disease modifying treatment of Parkinson's Disease. Providing information on the project, its aims, and updates on results and progress... Vaccines are cheap, safe, and easy to administer, making them a highly desirable solution for treating PD. Unfortunately, current vaccines are not very effective at generating immune responses against alpha synuclein (aSyn), the protein which causes PD. This is because traditional vaccines generate only weak immune responses to proteins like aSyn that are also found in healthy individuals.